ATAD1 and malaria: Naturally acquired antibodies to MSP-119 can inhibit erythrocyte invasion by preventing the secondary processing that releases this fragment from the rest of the MSP-1 complex [9,11,12], and are associated with protection from clinical malaria in field studies [13–18].